Trials / Completed
CompletedNCT04451083
Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To investigate safety, tolerability and pharmacokinetics in Japanese healthy adult male subjects when FOY-305 is administered as multiple-dose orally.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FOY-305 | Multiple-dose of FOY-305 will be administered orally at 4 times/day. |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-08-17
- Completion
- 2020-08-17
- First posted
- 2020-06-30
- Last updated
- 2024-04-09
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04451083. Inclusion in this directory is not an endorsement.